AN2 THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.27 USD | 0.00% |
|
-6.20% | -88.92% |
| 16/05 | Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating | MT |
| 03/04 | North American Morning Briefing : Powell Awaited -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Other Biotechnology & Medical Research | 0.00% | -6.20% | -88.92% | -72.58% | - | 67.71M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ANTX Stock
- Charts AN2 Therapeutics, Inc.
- Comparison Chart